Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
01/2008
01/09/2008CN101103015A 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver X receptor modulators
01/09/2008CN101099462A Composition for controlling harmful bio-organisms and methodfor controlling harmful bio-organisms using the same
01/08/2008US7317020 Isolation and structure of Cribrostatin 6
01/08/2008US7317013 such as N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-{4-[1-(2-hydroxyethyl)piperidin-4-yl]butyl} guanidine dihydrochloride and optionally with g-coupled receptor agonist or bronchodilators, used for promoting hydration of mucosal surfaces; improved pharmacokinetics
01/08/2008CA2296031C Novel spiroazabicyclic heterocyclic compounds
01/03/2008US20080004447 Method for the Synthesis of a Benzimidazole Compound
01/03/2008US20080004317 Compounds
01/03/2008US20080004288 Indazole Sulphonamide Derivatives
01/03/2008US20080004278 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease
01/02/2008EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
01/02/2008EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
01/02/2008EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/02/2008CN101098869A 5-heteroaryl thiazoles and their use as p13k inhibitors
01/02/2008CN101098861A Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
01/02/2008CN101098858A 吲唑磺酰胺衍生物 Indazole sulfonamide derivative
01/02/2008CN101098857A Nitro indazole derivatives
01/02/2008CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/02/2008CN100358900C Novel compounds
01/02/2008CN100358898C Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
01/02/2008CN100358897C 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives
01/02/2008CN100358889C Imidazol-4-yl-ethynyl-pyridine derivatives
01/02/2008CN100358876C Crystalline modifications of triazinylaminostilbenes
01/01/2008US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors
01/01/2008US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds
01/01/2008US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
12/2007
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007CN101091488A Composition for controlling harmful bio-organisms and methodfor controlling harmful bio-organisms using the same
12/26/2007CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/25/2007US7312336 Ligands for the delta opiod receptor; novel compounds which possess a piperidine ring with an exocyclic double bond do not show significant convulsive effects when administered systemically
12/20/2007US20070293536 Salts and polymorphs of a potent antidiabetic compound
12/20/2007US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007US20070293502 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
12/20/2007US20070292887 Immunohistochemical Methods
12/20/2007US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/19/2007EP1353694B1 Combinations of ezetimibe with aspirine for treating vascular conditions
12/19/2007CN100355755C Diazabicyclic central nervous system active agents
12/19/2007CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/18/2007US7309802 Preparation of isoxazolin-3-ylacylbenzene
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/13/2007US20070287632 Sulphur-Containing Oils For Controlling Plant Pathogens And Stimulating Nutrient Uptake
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864680A2 Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
12/12/2007CN100354282C Thienopyridazinones and their use in modulation of autoimmune disease
12/12/2007CN100354281C Process for preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3] benzotiazepines
12/12/2007CN100354268C Novel triazolo pyrimidine compounds
12/12/2007CN100354265C Pharmaceutical compounds
12/11/2007US7307195 Process of converting ethylbenzene to styrene using a graphite nanocatalysts
12/11/2007US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007CA2546165C Preparation of arthropodicidal oxadiazines
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1656183B1 Treatment of male sexual dysfunction
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101082058A Method of resolution and racemic mixture of nucleoside enantiomers
12/05/2007CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/05/2007CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist
12/04/2007US7304156 Preparation of aminopyrimidine compounds
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007CA2227039C One pot synthesis of 2-oxazolidinone derivatives
11/2007
11/29/2007US20070276144 Synthesis Of Discodermolide And Variants Thereof
11/29/2007US20070276141 Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine
11/29/2007US20070275908 Methods and Compositions for the Enzymatic Synthesis of Gangliosides
11/29/2007US20070274928 Novel Cyclic Oxygenated Compounds Having Cooling, Fragrance, and Flavor Properties, and Uses Thereof
11/28/2007EP1448201B1 N-(indolcarbonyl-)piperazine derivatives for the treatment of obesity
11/28/2007CN101080403A Novel hydantoin derivatives as metalloproteinase inhibitors
11/28/2007CN101080387A Process for the preparation of N- (4-piperidinyl) -N-ethyl-phenylacetamides from N-boc-4-oxopiperidine
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351246C Process for selective derivatization of taxanes
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/22/2007US20070270467 Substituted piperidines as modulators of dopamine neurotransmission
11/22/2007US20070270427 vascular endothelial growth factor receptor inhibitors such as N2-(3-methyl-1H-indazol-6-yl)-N4-{3-[(methylsulfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate, used as anticarcinogenic, antitumor or antiproliferative agents
11/21/2007CN101076538A Steroids for cancer treatment
11/21/2007CN101076517A Substituted piperidines as modulators of dopamine neurotransmission
11/21/2007CN100349877C Preparation of aminopyrimidine compounds.
11/20/2007US7297703 Macrolides
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007US20070265325 Nitro Indazole Derivatives
11/15/2007US20070265286 Quinazoline derivatives as VEGF inhibitors
11/15/2007US20070265282 Use of ticagrelor treating myocardial infarction, thrombotic stroke, angina and transient ischemic attacks
11/15/2007US20070264333 Method of treatment
11/14/2007CN101072778A Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
11/08/2007US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007US20070259914 Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5.
11/08/2007US20070259864 N-benzyl-N-{2-[7-(4-cyanobenzyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]ethyl}methane-sulfonamide; trial and ventricular arrhythmias; pharmacokinetics; electrophysiological activity; lowering daily clinical dose, lengthening duration of action; side effect reduction
11/07/2007EP1852424A2 Method for manufacturing isoxazoline-3-yL-acyl benzoles
11/07/2007EP1599460B1 Oxathiin carboxamide
11/07/2007CN101066952A Crystalline pharmaceutical
11/07/2007CN100347167C Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles
11/06/2007US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
10/2007
10/31/2007EP1537122B9 Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101062903A Hydroxylation of beta-dicarbonyls with zirconium catalysts
10/31/2007CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 105